Multi-million euro purchase for three high-containment lines for female and other hormonal preparations has finalized at Achema 2018.

Three high containment oral solid dosage (OSD) form production lines will installed plant in Siberia.

With a planned production capacity of more than a billion tablets per annum, the new facility will benefit from state-of-the-art manufacturing technology from GEA’s batch and continuous portfolio, including single-pot processing solutions — with unique features such as microwave drying and swinging bowl functionality to reduce drying times — MODUL® contained and wash-off-line rotary tablet presses, materials handling systems and MC BUCK® split valve technology.

A specialist in the development and production of antitubercular, antineoplastic, antiretroviral medicines and hospital antibiotics, Pharmasyntez has a product range of 115 products comprising dosage forms such as tablets, capsules, granules, infusion solutions, sterile powders, and injectables.

“Russian pharma has come a long way in the last seven years, since the introduction of the Pharma 2020 program. Almost USD 5 billion has been invested in the pharma industry, more than 30 new manufacturing facilities have been built and, now, more than 80 per cent of the life-saving drugs used in Russia are made in Russia!”.

“Today, more than 90 per cent of the hormone drugs used in the country are imported; Pharmasyntez, supported by the Ministry of Trade and Commerce, and the Institute of Endocrinology, decided to change that. As such, Pharmasyntez has invested more than EUR 50 million in the construction of a modern, GMP-compliant hormone facility.”

GEA is one of the largest suppliers of process technology to the food industry and to a wide range of other industries. In 2017, GEA generated consolidated revenues of around EUR 4.6 billion. The food and beverages sector, which is a long-term growth industry, accounted for around 70 percent.

"All rights reserved except agreement written by Emballage Digest or mention of the magazine''